Ertapenem Versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal Infections: Results of a Double-Blind, Randomized Comparative Phase III Trial

OBJECTIVE: To examine the clinical efficacy and safety of ertapenem, a novel β-lactam agent with wide activity against common pathogens encountered in intraabdominal infection. SUMMARY BACKGROUND DATA: Ertapenem has a pharmacokinetic profile and antimicrobial spectrum that support the potential for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Solomkin, Joseph S., Yellin, Albert E., Rotstein, Ori D., Christou, Nicolas V., Dellinger, E. Patchen, Tellado, Jose M., Malafaia, Osvaldo, Fernandez, Alvaro, Choe, Kyuran A., Carides, Alexandra, Satishchandran, Vilas, Teppler, Hedy
Formato: Artigo
Idioma:Inglês
Publicado em: 2003
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1522141/
https://ncbi.nlm.nih.gov/pubmed/12560782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.SLA.0000048551.32606.73
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados